Apnimed Financials - Benzinga

Apnimed Inc

APMDNASDAQ

Trade with Public

Trade with Public

$25.34

-0.88-3.34%

Last update: Sep 22, 10:47 AM

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Stock Report

Apnimed Financials

Apnimed (APMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M

Apnimed (NASDAQ:APMD) reported quarterly earnings of $3.91 per share which beat the analyst consensus estimate of $(0.34) by 1250 percent. The company reported $12.080 million in sales this quarter.

Benzinga Newsdesk